A PD-L2-based immune marker signature helps to predict survival in resected pancreatic ductal adenocarcinoma
Yiyin Zhang(Shanghai Medical College of Fudan University), Si Shi(Fudan University Shanghai Cancer Center)
Cited by 60
Related Papers
Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives
|Molecular Cancer|2021|2.2k
A miR-146a-5p/TRAF6/NF-kB p65 axis regulates pancreatic cancer chemoresistance: functional validation and clinical significance
|Theranostics|2020|169
Melatonin attenuates acute kidney ischemia/reperfusion injury in diabetic rats by activation of the SIRT1/Nrf2/HO-1 signaling pathway
|Bioscience Reports|2018|133
Targeting neoadjuvant chemotherapy-induced metabolic reprogramming in pancreatic cancer promotes anti-tumor immunity and chemo-response
|Cell Reports Medicine|2023|53
NLRP4 renders pancreatic cancer resistant to olaparib through promotion of the DNA damage response and ROS-induced autophagy
|Cell Death and Disease|2024|18